American healthcare company Abbott has launched Perfectly Simple - a new line of nutrition bars under its ZonePerfect brand. The new bars contain ten or fewer ingredients and are a good source of protein. They are free of gluten, ...
Tags: nutrition bars, good source of protein, free of gluten
Abbott will expand the current CE-IVD product labeling for its Vysis ALK Break Apart FISH Probe Kit to allow the test to be marketed in the European Union as a companion diagnostic. The test uses Abbott's proprietary fluorescence in situ ...
Tags: Abbott, anaplastic lymphoma kinase, ALK, FISH technology
Abbott has launched a new, Web-based, integrated laboratory informatics solution to help laboratories improve efficiency and productivity while minimizing errors. OneLab will allow labs to standardize processes across multiple locations ...
Tags: Abbott, OneLab, integrated laboratory informatics solution
Abbott Norge AS, a health care company, has deployed Cegedim's cloud-based customer relationship management (CRM) solution, Mobile Intelligence. Abbott also uses another pharma cloud-based mobile solution OneKey designed to improve ...
Tags: Abbott Norge AS, CRM, Mobile Intelligence
Abbott has signed an agreement to acquire all global rights to develop and commercialize AP214 from Action Pharma. AP214 is a hormone analogue which is being developed to prevent acute kidney injury associated with major cardiac surgery ...
Tags: AP214, Abbott, Action Pharma
BioView and Abbott have entered into a partnership agreement for the development of automated scanning solution to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in patients with advanced non-small cell lung cancer ...
Tags: BioView, Abbott, automated scanning solution, NSCLC
The boss of Holden has called on both sides of Australia's political spectrum to settle their differences and agree to support the local automotive sector ahead of what he believes will be a defining year for the industry. Holden chairman ...
Tags: Automotive Industry, political, federal election, government support
India-based Lupin Pharmaceuticals has launched Fenofibrate tablets, 48 mg and 145 mg strengths in the US. The company in the past has received the final approval for Fenofibrate tablets from the US Food and Drug Administration. The ...
Tags: Fenofibrate tablets, released tablets, high quality product
Ten biopharmaceutical companies, Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech and Sanofi have established a non-profit organization ...
Tags: biopharmaceutical companies, non-profit organization, new medicines
Abbott's Point of Care business has gained marketing and distributing rights for Abaxis' portable clinical chemistry analyzer and its reagent discs in the US and China (including Hong Kong). The system, Piccolo Xpress, contain all the ...
Tags: portable clinical chemistry analyzer, chemistry analyzer, reagent discs
The USFDA has approved Abbott's Humira (adalimumab) for the treatment of adult patients with moderate to severe Ulcerative Colitis (UC) when certain other medicines have not worked well enough. Humira, which works by inhibiting tumour ...
Tags: FDA, Abbott Humira, Ulcerative Colitis
Abbott has received CE mark approval for Architect HbA1c assay, designed to monitor treatment efficacy for diabetes patients. The chemiluminescent microparticle Architect HbA1c assay, which is designed for the quantitative determination ...
Tags: Architect HbA1c assay, Architect i immunoassay systems